USE OF PROTEIN TEBP AS A MARKER FOR BREAST CANCER

摘要

The present invention relates to the diagnosis of breast cancer. It discloses the use of protein TEBP (telomerase-binding protein p23) in the diagnosis of breast cancer. It relates to a method for diagnosis of breast cancer from a liquid sample, derived from an individual by measuring TEBP in said sample. Measurement of TEBP can, e.g., be used in the early detection or diagnosis of breast cancer.